![David Zhu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Zhu
Direktor/Vorstandsmitglied bei Bilayer Therapeutics, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Thomas A. Collet | M | - |
Bilayer Therapeutics, Inc.
![]() Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | 4 Jahre |
Joshua Korzenik | M | - |
Bilayer Therapeutics, Inc.
![]() Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
Robert Langer | M | 74 |
Bilayer Therapeutics, Inc.
![]() Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
June Huang | M | - |
Kendall Capital Partners
![]() Kendall Capital Partners Investment ManagersFinance Kendall Capital Partners Management LLC (Kendall Capital Partners) is a venture capital firm founded in 2021 by June Huang. The firm is headquartered in Boston, Massachusetts. | 3 Jahre |
Kirsten Chen | F | - |
Kendall Capital Partners
![]() Kendall Capital Partners Investment ManagersFinance Kendall Capital Partners Management LLC (Kendall Capital Partners) is a venture capital firm founded in 2021 by June Huang. The firm is headquartered in Boston, Massachusetts. | - |
Carlo Giovanni | M | - |
Bilayer Therapeutics, Inc.
![]() Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
Yen Chen Huang | M | - |
Bilayer Therapeutics, Inc.
![]() Bilayer Therapeutics, Inc. BiotechnologyHealth Technology Bilayer Therapeutics, Inc. is an American company that develops drugs for chronic disorders. The company was founded in 2020. The CEO is Thomas A. Collet. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 7 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen